Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chrysos

Showing results (131-140 of 192) with videos related to

Pageof 20
Sort By:
Pharmacoeconomics - Open|April 25, 2018
Systematic Review of Economic Models Used to Compare Techniques for Detecting Peripheral Arterial DiseaseEoin Moloney, Joanne O'Connor, Dawn Craig, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 15, 2021
Impact of a 4-year antimicrobial stewardship program implemented in a Greek tertiary hospitalKonstantina Chrysou, Olympia Zarkotou, Sofia Kalofolia, et al.
Plos One|January 25, 2023
The impact of the COVID-19 outbreak on emergency general surgery in the first German "hotspot region" Aachen-Heinsberg-A multicentre retrospective cohort studyAlexandros Chrysos, Iakovos Amygdalos, Priscila Nunes, et al.
Anticancer Research|February 19, 2002
Treatment of unresectable malignant abdominal, pelvic and thoracic tumors using abdominal pelvic and thoracic stop-flow chemotherapyE Chrysos, J Tsiaoussis, K Alexandra, et al.
Pathogens (Basel, Switzerland)|May 24, 2024
Seroprevalence of <i>Toxoplasma gondii</i> among HIV Positive Patients under Surveillance in Greek Infectious Disease Units: A Screening Study with Comparative Evaluation of Serological MethodsChrysa Voyiatzaki, Apollon Dareios Zare Chormizi, Maria E Tsoumani, et al.
Journal of Clinical Medicine|September 9, 2020
Current and Future Trends in Molecular Biomarkers for Diagnostic, Prognostic, and Predictive Purposes in Non-Melanoma Skin CancerTaxiarchis Konstantinos Nikolouzakis, Luca Falzone, Konstantinos Lasithiotakis, et al.
Microorganisms|July 27, 2024
Serological Screening and Risk Factors Associated with <i>Leishmania infantum</i> Positivity in Newly Diagnosed HIV Patients in GreeceChrysa Voyiatzaki, Apollon Dareios Zare Chormizi, Maria E Tsoumani, et al.
AIDS Research and Human Retroviruses|May 8, 2015
Treatment Modifications and Treatment-Limiting Toxicities or Side Effects: Risk Factors and Temporal TrendsNikos Pantazis, Mina Psichogiou, Vassilios Paparizos, et al.
AIDS (London, England)|November 13, 2021
HIV continuum of care: bridging cross-sectional and longitudinal analysesGiota Touloumi, Christos Thomadakis, Nikos Pantazis, et al.
HIV Clinical Trials|October 9, 2001
Virological and immunological response to HAART therapy in a community-based cohort of HIV-1-positive individualsG Touloumi, V Paparizos, H Sambatakou, et al.
Pageof 20

Showing results (131-140 of 192) with videos related to

Sort By:
Pageof 20
Pharmacoeconomics - Open|April 25, 2018
Systematic Review of Economic Models Used to Compare Techniques for Detecting Peripheral Arterial DiseaseEoin Moloney, Joanne O'Connor, Dawn Craig, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 15, 2021
Impact of a 4-year antimicrobial stewardship program implemented in a Greek tertiary hospitalKonstantina Chrysou, Olympia Zarkotou, Sofia Kalofolia, et al.
Plos One|January 25, 2023
The impact of the COVID-19 outbreak on emergency general surgery in the first German "hotspot region" Aachen-Heinsberg-A multicentre retrospective cohort studyAlexandros Chrysos, Iakovos Amygdalos, Priscila Nunes, et al.
Anticancer Research|February 19, 2002
Treatment of unresectable malignant abdominal, pelvic and thoracic tumors using abdominal pelvic and thoracic stop-flow chemotherapyE Chrysos, J Tsiaoussis, K Alexandra, et al.
Pathogens (Basel, Switzerland)|May 24, 2024
Seroprevalence of <i>Toxoplasma gondii</i> among HIV Positive Patients under Surveillance in Greek Infectious Disease Units: A Screening Study with Comparative Evaluation of Serological MethodsChrysa Voyiatzaki, Apollon Dareios Zare Chormizi, Maria E Tsoumani, et al.
Journal of Clinical Medicine|September 9, 2020
Current and Future Trends in Molecular Biomarkers for Diagnostic, Prognostic, and Predictive Purposes in Non-Melanoma Skin CancerTaxiarchis Konstantinos Nikolouzakis, Luca Falzone, Konstantinos Lasithiotakis, et al.
Microorganisms|July 27, 2024
Serological Screening and Risk Factors Associated with <i>Leishmania infantum</i> Positivity in Newly Diagnosed HIV Patients in GreeceChrysa Voyiatzaki, Apollon Dareios Zare Chormizi, Maria E Tsoumani, et al.
AIDS Research and Human Retroviruses|May 8, 2015
Treatment Modifications and Treatment-Limiting Toxicities or Side Effects: Risk Factors and Temporal TrendsNikos Pantazis, Mina Psichogiou, Vassilios Paparizos, et al.
AIDS (London, England)|November 13, 2021
HIV continuum of care: bridging cross-sectional and longitudinal analysesGiota Touloumi, Christos Thomadakis, Nikos Pantazis, et al.
HIV Clinical Trials|October 9, 2001
Virological and immunological response to HAART therapy in a community-based cohort of HIV-1-positive individualsG Touloumi, V Paparizos, H Sambatakou, et al.
Pageof 20